Vaccination

EU calls on US to push exports to counter vaccine shortage

The European Union called on the United States Friday to start boosting its vaccine exports to contain the global COVID-19 crisis, and said that the U.S. backing of patent waivers would provide only a long-term solution at ...

Oncology & Cancer

Probe to detect spread of breast cancer gets distribution boost

A device co-developed by a University of Houston (UH) physicist to detect the spread of breast cancer and allow physicians to better plan intervention is extending its market reach, bringing it another step closer to clinical ...

Oncology & Cancer

Approval of test to diagnose adrenal cancer

A new analytical test has been launched in the UK that provides sensitive, specific and efficient predictive analysis of a rare form of cancer from a simple urine sample. The ACC steroid analysis service will be marketed ...

Immunology

Deciphering the enemy's ID

Immunologists at LMU have come up with a new technique that can be used both to fight tumors and to treat autoimmune diseases. A new grant from the Federal Ministry for Education and Research will enable the method to be ...

Other

GSK sees earnings rise amid good demand for vaccines

Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.

Diseases, Conditions, Syndromes

Artificial nose shows potential to treat breathing disorders

A respiratory simulation device, complete with an artificial nose made from a 3-D printer, is the subject of Miami University's newest patent and a potential breakthrough in researching, diagnosing and treating breathing ...

Medications

British court ruling backs patent protecting Lilly's Alimta

Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.

page 21 from 26